THBS1 and kidney disorder: Neovascularization induced by angiogenic factors is counterbalanced by the effects of angiogenic inhibitors, such as TSP-1, a glycoprotein expressed at very low levels in the healthy renal cortex and upregulated during some renal diseases [12].